AstraZeneca Pharma India Ltd. has announced the results of its 46th Annual General Meeting. All resolutions presented to the shareholders at the AGM, which was held on August 14, were duly passed with the necessary majority. This outcome confirms strong shareholder approval for the company's proposals, providing a clear mandate for management to proceed with the decisions ratified at the meeting. This is a positive indication of investor confidence in the company's strategic direction.